{"id":254563,"date":"2012-11-17T04:43:46","date_gmt":"2012-11-17T04:43:46","guid":{"rendered":"http:\/\/www.eugenesis.com\/astar-scientist-wins-european-molecular-biology-organization-embo-young-investigatorship-award\/"},"modified":"2012-11-17T04:43:46","modified_gmt":"2012-11-17T04:43:46","slug":"astar-scientist-wins-european-molecular-biology-organization-embo-young-investigatorship-award","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biology\/astar-scientist-wins-european-molecular-biology-organization-embo-young-investigatorship-award.php","title":{"rendered":"A*STAR Scientist Wins European Molecular Biology Organization (EMBO) Young Investigatorship Award"},"content":{"rendered":"<p><p>    Dr Bruno Reversade first scientist outside of Europe to win    prestigious European award  <\/p>\n<p>    Singapore, Nov 15, 2012 - (ACN Newswire) - Dr Bruno Reversade    from A*STAR's Institute of Medical Biology (IMB) is the first    scientist based outside Europe to be awarded the prestigious    European Molecular Biology Organization (EMBO) Young    Investigatorship. The EMBO Young Investigator Programme (YIP)    recognizes the most outstanding and promising young independent    scientists leading their first labs in Europe and EMBO    cooperation partner countries[1]. More details on the other    2012 EMBO YIP awardees, EMBO YIP and EMBO can be found at Annex    A.  <\/p>\n<p>    Dr Reversade was awarded the YIP as the judging panel deemed    him to be \"a really original scientist\" with outstanding    research output. His research examines rare genetic conditions    which provide insights into common diseases and traits that    affect the general population. His current research on    twinning, which suggests that the birth of identical twins    could be genetically triggered, was described as \"highly    innovative and original - probably unique\" by the judging    panel.  <\/p>\n<p>    Dr Reversade has published seven papers in a short span of four    years since he became an independent investigator under the    A*STAR Investigatorship (A*I)[2] scheme in 2008. Four of these    papers were published in the prestigious journal Nature    Genetics.  <\/p>\n<p>    Dr Reversade, Senior Principal Investigator at IMB, said, \"I am    genuinely honoured to receive the EMBO Young Investigatorship.    I am most grateful to my team as this is certainly not one    person's work and to Singapore for providing such a conducive    research environment.\"  <\/p>\n<p>    Prof Sir David Lane, A*STAR Chief Scientist and EMBO member    said, \"Bruno was the first A*STAR Investigator recipient we    recruited for his promise and potential as part of A*STAR's    efforts to support and promote early independence and career    development of the best scientists of the next generation. His    research is patient-driven with strong clinical relevance and    we are delighted that his work has been recognized with this    prestigious award, which is a true mark of scientific    excellence.\"  <\/p>\n<p>    Mr Lim Chuan Poh, A*STAR Chairman, said, \"Bruno is a very    promising young scientist. He epitomises the quality of    scientists we want to develop in A*STAR to become the next    generation of scientific leaders. Bruno's award is not only a    testament to his personal talent and abilities, it also speaks    of the excellent scientific work that is possible in the    conducive research environment that has been created in A*STAR    and Singapore.\"  <\/p>\n<p>    Dr Reversade will receive an award of 15,000[3] Euros per year    for the three years of his membership as well as extensive    support from EMBO for networking interactions and other career    development opportunities. More information on the benefits of    the EMBO YIP can be found at <a href=\"http:\/\/www.embo.org\/programmes\/yip\/programme.html\" rel=\"nofollow\">http:\/\/www.embo.org\/programmes\/yip\/programme.html<\/a>    .  <\/p>\n<p>    Background on Dr Reversade  <\/p>\n<p>    Dr Reversade was the inaugural recipient of the A*I in 2008 (    <a href=\"http:\/\/sg.sg\/SOJzkq\" rel=\"nofollow\">http:\/\/sg.sg\/SOJzkq<\/a> ) , which was modelled    on the prestigious Howard Hughes Medical Institute (HHMI)    Investigatorship award. The A*I was initiated as a platform to    support and promote early independence and career development    of the next generation of world leaders in scientific research    in biomedical sciences, physical sciences and engineering    research. More information on the A*I can be found at <a href=\"http:\/\/www.a-star.edu.sg\/tabid\/88\/default.aspx\" rel=\"nofollow\">http:\/\/www.a-star.edu.sg\/tabid\/88\/default.aspx<\/a> .  <\/p>\n<\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/nz.finance.yahoo.com\/news\/star-scientist-wins-european-molecular-150000481.html\" title=\"A*STAR Scientist Wins European Molecular Biology Organization (EMBO) Young Investigatorship Award\">A*STAR Scientist Wins European Molecular Biology Organization (EMBO) Young Investigatorship Award<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Dr Bruno Reversade first scientist outside of Europe to win prestigious European award Singapore, Nov 15, 2012 - (ACN Newswire) - Dr Bruno Reversade from A*STAR's Institute of Medical Biology (IMB) is the first scientist based outside Europe to be awarded the prestigious European Molecular Biology Organization (EMBO) Young Investigatorship. The EMBO Young Investigator Programme (YIP) recognizes the most outstanding and promising young independent scientists leading their first labs in Europe and EMBO cooperation partner countries[1]. More details on the other 2012 EMBO YIP awardees, EMBO YIP and EMBO can be found at Annex A.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biology\/astar-scientist-wins-european-molecular-biology-organization-embo-young-investigatorship-award.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577690],"tags":[],"class_list":["post-254563","post","type-post","status-publish","format-standard","hentry","category-biology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/254563"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=254563"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/254563\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=254563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=254563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=254563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}